InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,859.85
(
0.77%
)
US TECH 100
19,867.20
(
-0.16%
)
Dow Jones
43,065.22
(
0.47%
)
Brent Oil
73.59
(
-1.77%
)
Bitcoin
65,736.20
(
-0.49%
)
Post# of 253368
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120566
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 228435

Monday, 05/11/2020 12:25:05 PM

Monday, May 11, 2020 12:25:05 PM

Post# of 253368
Histogen/CNAT pursuing androgenetic alopecia:

https://www.globenewswire.com/news-release/2020/05/11/2031027/0/en/Histogen-Receives-US-FDA-IND-Approval-to-Initiate-Phase-1b-2a-Trial-of-HST-001-in-Androgenic-Alopecia.html

HST 001, or Hair Stimulating Complex (HSC), is intended to be a physician-administered therapeutic for hair loss. HSC is anticipated to be a safe, minimally-invasive treatment that promotes new hair growth where existing treatments only reduce hair loss. HSC is manufactured to enrich for growth factors including KGF, VEGF, and follistatin, which are involved in signaling stem cells in the body, and have been shown to be important in hair formation and the stimulation of resting hair follicles.

Good luck with that, LOL.

The ticker symbol will change to HSTO when the reverse-merger with CNAT closes.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up